US Codex
Bill
Notes

To authorize the use of certain Department of Defense funds for combating opioid trafficking and abuse in the United States.

H.R. 5546 · 115th Congress · Apr 18, 2018 · Lineage

A BILL

Section 1 Findings; sense of Congress

(a)
Findings— Congress makes the following findings:
(1)
Over the past 15 years, the rise in opioid use in the United States has grown exponentially.
(2)
According to the Office of National Drug Control Policy, the number of deaths related to opioids in the United States in 2016 was 42,269.
(3)
Addiction and misuse of prescription opioids continues to rise. According to the Office of National Drug Control Policy, in 2016, 11.5 million people misused prescription opioids.
(4)
The predominant amount of precursors for fentanyl production are illicit trafficked from China.
(5)
The Office of National Drug Control Policy is the lead agency for confronting the epidemic of opioid addiction and trafficking in the United States.
(6)
The Department of Homeland Security is the lead agency in securing United States borders from illicit trafficking.
(7)
The Department of Defense plays a vital supporting role in addressing the illicit nature of the opioid epidemic through intelligence analysis, education, and assistance to other departments and agencies in dealing with this challenge.
(b)
Sense of Congress— It is the sense of Congress that—
(1)
the Department of Defense should provide support for interagency efforts to combat the national opioid epidemic; and
(2)
the role of the Department of Defense is critical to identifying transnational criminal organizations that allow illicit opioids to enter the United States.

Sec. 2 Department of Defense support for combating opioid trafficking and abuse

Of the amounts authorized to be appropriated for the Department of Defense for National Guard counterdrug programs for fiscal year 2019, $20,000,000 may be used to provide support for United States interagency efforts to combat opioid trafficking and abuse in the United States.